The Denver Post

FDA panel backs Ortho Evra birth-control patch despite risks

ADELPHI, Md. — A panel of federal health advisers said Friday that a birth-control patch from Johnson & Johnson probably carries a higher risk of blood clots than older drugs but should remain ...
MM&M

FDA calls for label revision on Ortho Evra birth-control patch

The FDA announced a revision to the labeling for the Ortho Evra birth-control patch, warning that women taking the drug may be exposed to 60% more estrogen than if they were taking a typical 35 ...
Medscape

Ortho Evra Patch Linked to Risk for Venous Thromboembolism

September 21, 2006 — The US Food and Drug Administration (FDA) and Ortho-McNeil Pharmaceutical (a Johnson & Johnson company) have notified healthcare professionals regarding changes to the safety ...
Medscape

Ortho Evra Contraceptive Patch Linked to Increased Estrogen Exposure

Nov. 11, 2005 — The U.S. Food and Drug Administration (FDA) approved new labeling today regarding the increased level of estrogen exposure associated with use of an ethinyl estradiol/norelgestromin ...
Monthly Prescribing Reference

First Generic Ortho Evra Patch Launched

Mylan announced that it has launched Xulane (Norelgestromin/Ethinyl Estradiol Transdermal System) 150/35mcg per day, the generic version of Janssen’s Ortho Evra transdermal patch. Mylan received final ...
Houston Chronicle

(PZ) Parker & Waichman, LLP Believes New Study On Ortho Evra Provides Further Evidence That the Birth Control Patch is Associated With Higher Rates of Blood Clots

NEW YORK, Sept. 21, 2006 (PRIMEZONE) -- Parker & Waichman, LLP (www.yourlawyer.com) announced that it believes a new study provides further evidence that Ortho Evra is dangerous and should be recalled ...
Time

Did Johnson & Johnson Bury Data on Ortho-Evra’s Health Risks?

It’s should be common knowledge that the Johnson & Johnson (J&J) Ortho-Evra birth-control patch has more risks than the birth control pill (it’s on the label) — because it exposes women to higher ...
Grand Forks Herald

FDA approves update to label on Ortho birth control patch

The U.S. Food and Drug Administration approved additional changes to the Ortho Evra Contraceptive Transdermal (Skin) Patch label to include the results of a new epidemiology study that found that ...
MM&M

FDA urges caution on Ortho patch data

Preliminary data on the risk of blood clots with the Ortho Evra contraceptive patch warrant further analysis but no immediate regulatory action, the FDA said today.Ortho Women’s Health, a unit of ...
CBS News

Birth Control Patch Still Killing Women 2 Years After FDA Review

When I saw the Today Show's exposé of Johnson & Johnson (JNJ)'s Ortho Evra birth control patch-- it fills women with an uninterrupted flow of hormones that create lethal blood clots -- my first ...
Reuters

FDA advisers: Ortho Evra patch needs clearer label

ADELPHI, Maryland (Reuters) - U.S. drug advisers recommended that the label for Johnson and Johnson's Ortho Evra birth control patch be simplified to better explain the risk of blood clots. In a 20 to ...
Reuters

FDA advisers stand behind Ortho Evra patch

ADELPHI, Maryland (Reuters) - Drug advisers recommended that the label for Johnson and Johnson's Ortho Evra birth control patch should be simplified to better explain the risk of blood clots. Advisers ...